Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;20(5):383-389.
doi: 10.1080/17460913.2025.2472594. Epub 2025 Mar 4.

Repair capacity of Taenia solium extraparenchymal cysts: radiological and in vitro evidence

Affiliations

Repair capacity of Taenia solium extraparenchymal cysts: radiological and in vitro evidence

Andrea Toledo et al. Future Microbiol. 2025 Apr.

Abstract

Extraparenchymal neurocysticercosis (EP-NC) responds poorly to anthelmintic treatment. Several factors are involved in this low responsiveness, including the host's heterogeneous immune response and the ability of the parasite to evade it. In this study, we present radiological and in vitro findings that demonstrate that Taenia solium cysts have the capacity to repair from injuries. Six patients (three with cases of subarachnoid, two with cases of intraventricular, and one with a case of mixed subarachnoid and intraventricular cysts) presented with neurological complaints and underwent either medical or surgical treatment. Follow-up magnetic resonance imaging (MRI) showed apparent resolution of the cysts. However, months later (10-56) new MRI scans revealed cysts at the same sites observed before treatment. Cysts surgically removed were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum. Monthly assessments demonstrated the growth of the parasites and the release of HP-10. Our findings demonstrate the ability of T. solium extraparenchymal cysts to grow and repair themselves. This capacity is likely another factor involved in the disease's poor treatment response.

Keywords: Neurocysticercosis; Taenia solium; extraparenchymal neurocysticercosis; in vitro tests; magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Figures

Figure 1.
Figure 1.
MRI images from patients (#1 to #4) with subarachnoid neurocysticercosis (NC) at initial presentation (a) Arrows point the cysts), after treatment (b) and at relapse (c).
Figure 3.
Figure 3.
Photographic records of the two parasites (a and b) throughout the observational period. Bar scale: 10 mm.
Figure 2.
Figure 2.
Magnetic resonance imaging (MRI) scans of patients (#1 to #4) with ventricular NC at initial presentation (a) Arrows point the cysts), after treatment (b) and at relapse (c).
Figure 4.
Figure 4.
Parasite-specific antigen (HP10) concentrations in the medium during each month of observation for each parasite. Ctrl, control.

Similar articles

References

    1. Rodríguez-Rivas R, Flisser A, Norcia LF, et al. Neurocysticercosis in Latin America: current epidemiological situation based on official statistics from four countries. PLOS Negl Trop Dis. 2022;16(8):e0010652. doi: 10.1371/journal.pntd.0010652 - DOI - PMC - PubMed
    2. • Interesting work showing the current epidemiological trend of NC in Latin America.

    1. Serpa JA, White AC Jr.. Neurocysticercosis in the United States. Pathog Glob Health. 2012;106(5):256–260. doi: 10.1179/2047773212Y.0000000028 - DOI - PMC - PubMed
    1. Abraham A, Schmidt V, Kaminski M, et al. Epidemiology and surveillance of human (neuro)cysticercosis in Europe: is enhanced surveillance required? Trop Med Int Health. 2020;25(5):566–578. doi: 10.1111/tmi.13384 - DOI - PubMed
    1. Fleury A, Carrillo-Mezo R, Flisser A, et al. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther. 2011;9(1):123–133. doi: 10.1586/eri.10.150 - DOI - PubMed
    2. • Good review presenting the main characteristics of subarachnoid basal NC.

    1. Takayanagui OM, Haes TM.. Update on the diagnosis and management of neurocysticercosis. Arq Neuro-Psiquiatr. 2022;80(5 suppl 1):296–306. doi: 10.1590/0004-282X-ANP-2022-S115 - DOI - PMC - PubMed

LinkOut - more resources